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. A) FITC-Casein activity assay of several ADEP fragments and derivatives. Shown is the activity on SaClpP, normalized to the internal standard 01. Each experiment was performed in triplicates. B) Labeling of recombinant SaClpP with three photoprobes 235, 266 and 288. Figure S2 . A) Membrane fraction of concentration dependent in situ labeling in S. aureus NCTC8325 with probe 235 and B) overlay (green) with western blot, performed with SaClpP antibody. Bacteria were grown to stationary phase, incubated for one hour, irradiated with UV light for 15 min, lysed and clicked to rhodamine azide and visualized via fluorescence. C) shows analytical labeling in a ΔclpP strain in comparison to the wild type strain. Figure S3 . A) 2D structure of ADEP (PDB:5vz2) and ADEP-derived photoprobes 266 and 288. Common structural scaffold is shown in blue, important hydrophobic interactions between ADEP and amino acids in the binding site (green: monomer 1, orange: monomer 2) of SaClpP in red (Ile 29 
is shown twice for clarity). B) Distance values between atoms connected by a dashed line in A)
as measured in the equilibrated crystal structure ClpP 5vz2 and as used for pharmacophore constraints during the broadsampling step of the docking procedure, respectively. Figure S4 . Details of the diflourophanylalanine and acyl-chain moieties binding to the hydrophobic subpockets of SaClpP, exemplary shown for 266. A) Double bond (highlighted with a green circle) of the side extension acting as a spacer (black arrow) between two hydrophobic moieties binding in buried subpockets. B) Difluorophenylalanine as located in it's subpocket. Atom color scheme: hydrogen: white, other atoms types see Figure 2. We explored why replacement of the difluorophenylalanine by azidophenylalanine (compounds 07, 08)
as well as any changes in the acyl-chain (compounds 02, 03, 04, 06, and 09) lead to inactive compounds. Comparing the position of these moieties in the docked and experimental structures ( Figure   2 ), showed that their position in the binding site is highly conserved. In Figure S4 the two moieties are shown in detail as they protrude into their respective hydrophobic subpockets of the ClpP binding site.
It can be seen that the amide group in combination with the double bond are located directly in front of the -helix dividing the two subpockets, thus effectively forming a rigid spacer (black arrow) which allows for optimal placement of the difluorophenylalanine and the acyl-chain in their respective subpockets.
The absence of this double bond (02, 03, 04, 09) induces more flexibility in this region of the ligand, which lowers the probability for a proper placement. In addition, the presence of an alkyne handle at the end of the aliphatic side extension (02, 03, 04, 06, 09) might prohibit the necessary adaption of the chain to the long, yet narrow and bend subpocket (see position of the acyl-chain in Figure S4 A).
In Figure S4 B the difluorophenylalanine-moiety is shown together with the surface of the surrounding protein. It can be clearly observed that the round-shaped subpocket is perfectly adapted to the ligand moiety, thus the long and rigid azide group of 07 and 08 would clash with the protein as indicated with the black arrow. 
Biochemical Procedures

S. aureus strains and media
The S. aureus strain NCTC8325 was obtained from Institute Pasteur, France and grown in B medium.
The corresponding ΔclpP strain was constructed as published previously [1] and grown in BHB medium.
Bacterial growth media: LB medium (yeast extracts 5.0 g/L, tryptic peptone 10.0 g/L, NaCl 5.0 g/L); B medium (LB-broth 20.0 g/L, K2HPO4 1.0 g/L); BHB medium (brain heart infusion 17.5 g/L, Na2HPO4 2.5 g/L, glucose 2 g/L, tryptic peptone 10 g/L, NaCl 5 g/L).
Defined growth conditions
For an overnight culture 5 mL of the respective medium and 5 µL of the bacterial glycerol stock were shaken in a culture tube at 37 °C and 200 rpm. Day cultures were grown in 250 mL flasks with four baffles, with 50 mL medium and 1:100 inoculations with the overnight culture. Bacterial glycerol stocks were prepared out of 600 µL overnight culture and 400 µL sterile glycerol and frozen at -80 °C. For growth curves, OD600 measurements (Eppendorf BioPhotometer) were conducted every 30 to 60 minutes with 1:10 dilution of the bacterial suspension.
Determination of MIC values
The minimal inhibitory concentration (MIC) is defined as the concentration of a compound sufficient to fully inhibit visible growth of bacteria. The outer rows of a clear flat bottom 96 -well plate were filled with 150 µL medium as sterile control without any bacteria or compounds. 75 µL medium were provided in the remaining wells and 75 µL of DMSO or compound (1:200) in medium were added in the first column.
For a dilution series 75 µL were taken out of the first column and were diluted 1:1 with the medium in the second column, and so on. An overnight culture of the desired bacteria was diluted 1:5000 with medium and 75 µL were added to all inner wells. The bacteria were incubated for 18 h at 37 °C and 200 rpm. The MIC of the substances was defined as the lowest concentration at which no bacterial growth could be observed. [2] [3] [4] The Gateway cloning system (Life Technologies) was utilized to clone a C-terminal STREP-II affinity tagged SaClpP construct into pET301 expression vectors. 1 L LB-medium was inoculated with 10 mL [5, 6] The aim of this assay was to determine the proteolytic activity of ClpP in the presence of different 
Protein expression and purification
FITC-Casein Assay
Labeling in S. aureus intact cells
Bacteria were grown in a 250 mL Erlenmeyer flask with four baffles on the bottom. 50 mL B medium were inoculated with 0.5 mL overnight culture and the bacteria were grown until they reached stationary phase, with an OD600 between 5.5 and 6.5. Cultures were collected in a 50 mL falcon tube and centrifuged at 6000×g for 10 min at 4 °C. The supernatant was disposed and the pellet was washed with PBS and then resuspended in PBS to obtain a suspension with OD600 = 40. 
Western Blot Analysis
For western blot analysis, 5 µL marker (Serva Pink Color Protein Standard II) was used during SDS-PAGE. Before blotting, the gel was washed twice in blotting buffer ( 
Labeling in S. aureus intact cells, MS-based
Bacteria were grown in a 250 mL Erlenmeyer flask with four baffles on the bottom. 50 mL BHB medium were inoculated with 0.5 mL overnight culture and the bacteria were grown until they reach stationary phase, with an OD600 between 6.5 and 7.5. Cultures were collected in a 50 mL falcon tube and centrifuged at 6000×g for 10 min at 4 °C. The supernatant was disposed and the pellet was washed with PBS and then resuspended in PBS to get a suspension with OD600 = 40. To 990 µL of this suspension in a microcentrifuge tube, 10 µL of photoprobe (1 mM BH266, BH288 in DMSO) or DMSO was added and the tube was briefly mixed by vortexing. After 1 h incubation at room temperature in the dark, the suspension was diluted with 1 mL PBS and transferred into culture dishes (5.5 cm diameter) and irradiated with UV light (365 nm, Philips TL-DBLB18W) under cooling for 14 min, while the dishes were shaken shortly after 7 min. The irradiated bacterial suspension was transferred to 2 mL microcentrifuge tubes and after centrifugation (6000×g, 10 min, 4 °C) the supernatant was removed, the pellets were washed with 1 mL PBS and were stored over night at -80 °C.
Pellets were resuspended in 1 mL PBS (4 °C), lysostaphin (5 µL, 10 mg/mL) was added and shaken at 37 °C at 14000 rpm for 1 h. After the addition of SDS (20 µL 20% in PBS, final concentration 0.4%) the suspension was sonicated (10 sec, 20% intensity). The lysate was centrifuged at 17000×g for 60 min at Identification was done with at least 2 unique peptides and quantification only with unique peptides.
Statistical analysis was performed with Perseus 1.6.0.6. LFQ ratios were log2(x) transformed. −log10(pvalues) were obtained by a two sample t-test over three biological replicates. Putative contaminants, reverse peptides and peptides only identified by site were deleted. Values were filtered for two in at least one group. Cut off lines were set at -log10 (p-value) of 1.3 and at t-test difference of 3. p-values were corrected by permutation based FDR > 0.5.
Modeling Studies
Computational Methods
In this study, the ADEP variants 266 and 288 were modeled into the binding site of the SaClpP protein presenting their possible binding modes. The applied procedure is based on a docking pipeline, which was developed and optimized specifically for the docking of macrocyclic compounds. [7] In addition, to evaluate the performance of the pipeline and optimize its parameters for the molecular system at hand, first re-docking experiments of the co-crystallized crystallized ADEP molecule ( Figure 2C ) into its binding site in SaClpP were performed using the PDB:5vz2 protein-ligand complex. With the docking pipeline presented herein, a binding pose of the ADEP molecule with a root-mean-square deviation of all heavy ligand atoms (RMSD) of 1.6 Å (data not shown) from those of the equilibrated holo-structure (ClpP 5vz2 ) could be achieved, thereby assuring the suitability of the procedure for docking studies of the SaClpPligand system. The so optimized and validated docking parameters were afterwards applied for the prediction of the bound conformations of compounds 266 and 288 into the same SaClpP protein structure (ClpP 266 and ClpP 288 ).
Structure preparation
The 3D structures of 266 and 288 were built with Avogadro. [8] The SaClpP protein and ADEP ligand molecules were taken from crystallized complex structure PDB:5vz2. For computational efficiency the tetradecameric protein system was reduced to a dimeric ClpP structure comprising one ADEP ligand.
All crystallized water molecules were removed and missing hydrogen atoms were added to the protein and ADEP using the tleap module of Amber16/AmberTools17(AMBER17 suite) [9] and Avogadro, respectively.
Parameterization
Amber Force Field ff14SB [10] and TIP3P [11] parameters were used for all protein atoms and water and sodium ions of the solvent. For the three ligands General Amber Force Field [12] parameters were used and point charges were derived as follows: initial atomic charges were calculated with the antechamber module of AmberTools17 on the AM1-BCC level of theory. After minimization and heat-up (see below) a molecular dynamics (MD) simulation in gas phase was performed for 4 μs at 300 K. The trajectory was clustered with cpptraj [13] in dihedral space based on the four most flexible torsions of the macrocycle.
The centroid structures of the largest 10 clusters were further optimized on the HF/6-31G(d) level using the Gaussian09 [14] program. Atomic charges were fit to the electrostatic potential employing the Merz-Singh-Kollman [15] scheme. A multi-configurational RESP procedure was performed for those 10 optimized structures to obtain the final set of point charges.
Molecular Dynamics (MD) simulations
All MD simulations were performed with Amber16 for the solvated system using periodic boundary conditions based on a truncated octahedron simulation box with a maximum distance of 20.0 Å from the solute. Sodium ions were added for neutralization. The system was minimized with the sander module of Amber16 first employing positional restraints with a force constant of 3.0 kcal/(mol*Å 2 ) on all protein and ligand atoms while adjusting the box size until a target density of 1.0 g/cm 3 was reached. Afterwards, a unrestrained conjugate-gradient energy minimization was performed for 20,000 steps. Each system was heated up to 300 K over 1.5 ns applying the following steps: initial heating to 20 K with the same restraints as above on all atoms, followed by a heat-up to 200 K with restraints only on non-solvent atoms and a fully unrestrained heat-up to the target temperature of 300 K. All heating steps were performed in the NVT, all following simulations in the NPT ensemble using the pmemd.cuda engine of Amber16 [16] [17] [18] with mixed-precision mode on graphics processing units. The electrostatic interactions were calculated with the Particle Mesh Ewald method [19] and bonds involving hydrogen atoms were constrained with the SHAKE [20] algorithm. Furthermore, periodic boundary conditions and a 12.0 Å cutoff for non-bonded interactions were applied. The Langevin [21] thermostat with a collision frequency of 4.0 ps -1 and the Berendsen [22] barostat were employed for controlling temperature and pressure, respectively.
For the ClpP 5vz2 crystal structure complex a simulations time of 100 ns was used employing a time step of 1 fs. The frames of the last 80 ns were aligned on the protein backbone and clustered hierarchically (agglomerative) with cpptraj using the average-linkage method and an epsilon cutoff of 2.0 Å. The representative structure of the most populated cluster was used as the equilibrated holo-ClpP 5vz2 complex and as a reference structure for the re-docking calculations of the ADEP ligand.
In addition, equilibrium simulations of a dimeric ClpP structure from Escherichia coli co-crystallized with ADEP variant ADEP1 (PDB:3mt6) [23] were performed using the same protocol. This structure was used for structural comparison (see Figure 2D ) as in PDB:5vz2 the β-sheet loops at the edge of the pore are missing.
Conformational sampling of ADEP, 266, and 288
In this step, a diverse set of conformations of the macrocyclic ring was generated for each ligand by 
Molecular Docking
All Molecular Docking calculations were performed with the molecular dynamics-based DynaDock [24] approach, which consists of a broadsampling and subsequent refinement step allowing for full receptor- Van-der-Waals radii of protein and ligand atoms, as well as 60% atom-overlap within the ligand were tolerated. To increase the efficiency of the broadsampling step, only poses were accepted which fulfilled a set of pharmacophore constraints as shown in Figure S3 . These constraints were based on known conserved features of the general binding mode of ADEPs and the analysis of the equilibrated ADEP-ClpP 5vz2 reference complex: They characterize the hydrophobic subpockets (A-D) as well as an important hydrophobic interaction (E) of the macrocycle with ClpP [24] . Different cut-off values for the constraints were evaluated and optimized during the re-docking calculations of ADEP (data not shown) and the molecular docking calculations of 266 and 288 were performed based on these optimized values. All poses of 266 (27x50) and 288 (26x50) generated in this way were subsequently refined using OPMD employing soft-core potentials on non-bonded interactions between any protein-ligand atoms to resolve any atomic overlap tolerated during broadsampling. For the OPMD simulations a simulation time of 55 ps was used, as this time was found to be sufficient to successfully resolve any broadsamplingbased overlap during the ADEP redocking simulations. The temperature was kept at 300 K and a time step of 1 fs was applied. Positional restraints were applied on all backbone atoms of protein residues located more than 20.0 Å away from any ligand atom using a force constant of 1000.0 kJ/(mol*nm 2 ).
Bonds involving hydrogen atoms were constrained with the SHAKE algorithm. All successfully refined poses (overlap =0) were ranked according to the RMSD of all scaffold atoms (blue in Figure S3 , shared by ADEP, 288 and 266) with respect to ADEP in ClpP 5vz2 (RMSD-ranking). Additionally, all refined poses were hierarchically clustered with cpptraj based on all ligand heavy-atoms using an epsilon cutoff of 4.0 Å and visually compared to ADEP in ClpP 5vz2 . For both molecules 266 and 288 three highly populated clusters were obtained, which all featured the same overall ring orientation, thus the one closest to the bound ADEP conformation was chosen as basis for subsequent MD studies. This choice was based on the rational that the structural fluctuations during MD could be expected to be in the same range as the differences between the clusters, thus the choice of the cluster would not be overly crucial.
All poses of this cluster were ranked according to the interaction score as implemented in DynaDock.
The two highest ranked poses according to the interaction score and the two best ranked poses from the RMSD-ranking were solvated, minimized, and heated to 300 K (for simulations details see MD section High resolution mass spectra were measured on a LTQ-FT Ultra provided by Thermo Fischer Scientific using ESI. Non-high resolution mass spectra were measured on a LCQ-Fleet by Thermo Fischer Scientific using HESI or a MSQ-Plus by Thermo Fischer Scientific using ESI.
All final compounds were characterized by HR-MS and 1 H and 13 C spectra. Intermediates were confirmed by MS and 1 H spectra. Compound 01 was synthesized as previously published. [6, 25] 
General procedures for the synthesis of ADEP fragments
Generel procedure A: Synthesis of esters using EDC·HCl and DMAP. [25, 26] The Boc-protected amino acid and the corresponding alcohol were dissolved in dichloromethane (DCM) and EDC (1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide)·HCl and DMAP (4-Dimethylaminopyridine)
were added. The reaction mixture was stirred at room temperature for several hours until TLC control showed complete consumption of the starting material. After the solvent was removed under reduced pressure, the residue was taken up in ethyl acetate and was washed with 1 M HCl (aq., 3×), saturated NaHCO3 (3×) and saturated NaCl solution (1×). The organic layer was dried over Na2SO4 and the solvent was removed under reduced pressure.
General procedure B: Deprotection of a Boc-group. [25, 26] The Boc-protected amino acid was dissolved in 40% TFA in DCM and the reaction mixture was stirred for 1.5 h at room temperature. Argon was forced over the reaction to evaporate the solvent, which gave the crude product.
General procedure C: Synthesis of amides. [25, 26] The acid was dissolved in dimethylformamide were added and the reaction mixture was stirred for 15 min. Subsequently the amino acid in DMF was added and the reaction mixture was stirred until TLC control showed complete consumption of the starting material. Ethyl acetate (5 times the reaction volume) was added to the reaction mixture and it was washed with 1 M HCl (aq., 3×), saturated NaHCO3 solution (3×) and saturated NaCl solution (3×).
The organic layer was dried over Na2SO4, the solvent was removed under reduced pressure and the crude product was purified by column chromatography (hexane/ethyl acetate). Analytical data are in accordance with those published in the literature. [25] 
Synthesis of ADEP fragments
(S)-2-(((benzyloxy)carbonyl)amino)-3-methoxy-3-oxopropyl acetyl-L-prolinate (15)
Deprotection was performed according to general procedure B, using amino acid derivative 14 ( Analytical data in accordance with those published in the literature. [25] 
(S)-2-((S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanamido)-3-methoxy-3oxopropyl acetyl-L-prolinate (16)
The protected amino acid 15 (980 mg, 2.50 mmol, 1.0 eq.) was dissolved in 18 mL methanol and added Analytical data are in accordance with those published in the literature. [25] 
(S)-2-((S)-3-(3,5-difluorophenyl)-2-(hept-6-ynamido)propanamido)-3-methoxy-3-oxopropyl acetyl-L-prolinate (09)
Deprotection was performed according to general procedure B, using 167 mg (310 µmol, 2.0 eq.) amino acid 16 and trifluoroacetic acid (1.0 mL, 40% in DCM) for 15 h. Hept-6-ynoic acid (20 µL, 99.7 mg/mL, 170 µmol, 1.1 eq.) was dissolved in 0.9 mL DMF and 64.8 mg (170 µmol, 1.1 eq.) HATU and 30.0 µL (742 mg/mL, 170 µmol, 1.1 eq.) DIPEA were added. After the mixture was stirred for 15 min, half of the crude product (123 mg, 155 µmol, 1.0 eq.) was added, dissolved in 0.76 mL DMF.
The reaction was stirred for 2 h at room temperature, diluted with 20 mL ethyl acetate and extracted with 1 M HCl (aq., 3×20 mL), saturated NaHCO3 solution (3×20 mL) and saturated NaCl solution (20 mL [27] N-Boc-4-bromophenylalanine (200 mg, 581 µmol, 1.0 eq.), CuI (11.1 mg, 58.0 µmol, 0.1 eq.), NaN3
(S)-3-(4-azidophenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid (17)
(113 mg, 1.74 mmol, 3.0 eq.), N,N′-Dimethylethylenediamine (DMEDA, 940 µL, 819 mg/mL, 87.0 µmol, 0.2 eq.), Na-ascorbate (115 mg, 581 µmol, 1.0 eq.) and NaOH (23.2 mg, 581 µmol, 1.0 eq.) were diluted in 5 mL ethanol/water (6/1) and heated to 100 °C. The reaction mixture was stirred for 24 h at 100 °C, diluted with 10 mL ethyl acetate and washed with 4 mL saturated NaCl solution. The aqueous phase was extracted with ethyl acetate (3×3 mL), the combined organic layers were dried over Na2SO4 and the solvent was removed under reduced pressure. The crude product was purified by column chromatography (DCM/MeOH/acetic acid 94/5/1) and yielded 100 mg (56%) of the product. 
Prop-2-yn-1-yl (S,E)-3-(4-azidophenyl)-2-(hept-2-enamido)propanoate (07)
Deprotection was performed according to general procedure B, using 69.0 mg (203 µmol, 1.0 eq.) amino acid 18 and trifluoroacetic acid (2.0 mL, 40% in DCM) for 1.5 h. All of the crude product was used for the amide synthesis according to general procedure C, using 40.0 µL (960 mg/mL, 223 µmol, 1.1 eq.) E-2-heptenoic acid, 85.0 mg (223 µmol, 1.1 eq.) HATU and 40.0 µL (742 mg/mL, 223 µmol, 1.1 eq.) DIPEA in 2.5 mL DMF for 18 h. Washing steps were carried out with 3 mL aqueous solution each. 38.0 mg (77%) of the product was obtained after purification with column chromatography (hexane/ethyl acetate 1/1). No total pure product was obtained; impurities were subtracted out. [28] N-Boc-3-aminophenylalanine (200 mg, 645 µmol, 1.0 eq.) was dissolved in 9 mL methanol and K2CO3
(S)-3-(3-aminophenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid (19)
(107 mg, 773 µmol, 1.2 eq) and Pd/C (10% on carbon, 17.6 mg) was added under argon atmosphere.
The reaction flask was flushed with hydrogen thrice and stirred for 20 h under hydrogen atmosphere.
Subsequently the flask was flushed with argon, the reaction mixture was filtered through Celite ® and the solvent was removed under reduced pressure. The crude product was used without further purification. [29] Sulfurylchloride (3.23 mL, 1.67 g/mL, 40.0 mmol, 1.1 eq.) was added to a suspension of NaN3 (2.60 g, 40.0 mmol, 1.1 eq.) in MeCN at 0 °C under argon atmosphere. After the reaction was stirred for 18 h at room temperature, it was cooled to 0 °C and imidazole (2.59 g, 38.1 mmol, 1.0 eq.) was added in portions. The reaction mixture was stirred for 3.5 h at room temperature and 80 mL ethyl acetate was added. The organic layer was washed with water (80 mL) and saturated NaHCO3 solution (80 mL) and
1H-imidazole-1-sulfonyl azide hydrogen chloride (Imidazolsulfonylazide 27)
was dried over Na2SO4. 10 mL HCl (4 M in dioxane) was added and the mixture cooled to 0 °C. The pure product was filtered off and washed with ethyl acetate. Yield with 20% ethyl acetate: 2.41 g. [28] The crude amine 19 (205 mg, 645 µmol, 1.0 eq.) was dissolved in 5 mL methanol and imidazolsulfonylazide 27 (134 mg, 773 µmol, 1.2 eq.) and CuSO4·H2O (1.61 mg, 6.45 µmol, 0.01 eq.)
(S)-3-(3-azidophenyl)-2-((tert-butoxycarbonyl)amino)propanoic acid (20)
were added. The reaction mixture was stirred for 16 h at room temperature and the solvent was removed under reduced pressure. The residue was dissolved in water and acidified to pH 3 with 1 M HCl (aq.).
The mixture was extracted with ethyl acetate (3×3 mL), dried over Na2SO4 and the solvent was removed under reduced pressure. The crude product was purified by column chromatography (hexane/ethyl acetate 3/1 to 1/1 + 2% acetic acid) and yielded 127 mg (64%) of a colourless solid. Rf=0.06
(hexane/ethyl acetate 3/1). 
Prop-2-yn-1-yl (S)-3-(3-azidophenyl)-2-((tert-butoxycarbonyl)amino)propanoate (21)
Amino acid derivative 21 was synthesized according to general procedure A using 127 mg (415 µmol, 1.0 eq.) amino acid 20, 240 µL (948 mg/mL, 415 µmol, 1.0 eq.) propargyl alcohol, 95.0 mg (498 µmol, 1.2 eq.) EDC·HCl and 3.00 mg (20.0 µmol, 0.1 eq.) DMAP in 4 mL DCM for 2 h. Washing steps were carried out with 5 mL aqueous solution each. 106 mg (74%) of a yellow solid was obtained. The product was used for the next step without further purification.
Prop-2-yn-1-yl (S,E)-3-(3-azidophenyl)-2-(hept-2-enamido)propanoate (08)
Deprotection was performed according to general procedure B, using 106 mg (308 µmol, 1.0 eq.) amino acid 21 and trifluoroacetic acid (2.5 mL, 40% in DCM) for 2 h. All of the crude product was used for the amide synthesis according to general procedure C, using 50.0 µL (960 mg/mL, 339 µmol, 
Prop-2-yn-1-yl (S)-2-((tert-butoxycarbonyl)amino)-3-(3,5-difluorophenyl)propanoate (28)
Amino acid derivative 28 was synthesized according to general procedure A, using 500 mg (1.66 mmol, 1.0 eq.) N-Boc-3,5-difluoro-phenylalanine, 95.8 µL (948 mg/mL, 1.66 mmol, 1.0 eq.)
propargyl alcohol, 309 mg (1.99 µmol, 1.2 eq.) EDC·HCl and 10.2 mg (83.1 µmol, 0.1 eq.) DMAP in 20 mL DCM for 3 h. Washing steps were carried out with 10 mL aqueous solution each. The crude product (459 mg) was deprotected according to general procedure B, using trifluoroacetic acid (10 mL, 40% in DCM) for 1 h. The deprotected product was used for the next step without further purification.
Prop-2-yn-1-yl (S)-3-(3,5-difluorophenyl)-2-(pent-4-ynamido)propanoate (04)
Synthesized according to general procedure C, using 81.0 mg (338 µmol, 1.0 eq.) compound 28, 
Prop-2-yn-1-yl (S)-3-(3,5-difluorophenyl)-2-(hex-5-ynamido)propanoate (03)
Synthesized according to general procedure C, using 81.0 mg (338 µmol, 1.0 eq.) compound 28, 41.7 mg (372 µmol, 1.1 eq.) 5-hexynoic acid, 142 mg (372 µmol, 1.1 eq.) HATU and 48.1 µL (742 mg/mL, 372 µmol, 2.2 eq.) DIPEA in 3 mL DMF for 24 h. Washing steps were carried out with 8 mL aqueous solution each. 41.0 mg (36% over three steps) of the product was obtained after purification with column chromatography (hexane/ethyl acetate 5/1). Rf =0.21 (hexane/ethyl acetate 5/1). 
Prop-2-yn-1-yl (S)-3-(3,5-difluorophenyl)-2-(hept-6-ynamido)propanoate (02)
Synthesized according to general procedure C, using 21.0 mg (87.9 µmol, 1.0 eq.) compound 28, Methyl (E)-hept-2-en-6-ynoate (29) [30] DMSO (4.05 mL, 1.10 g/mL, 57.1 µmol, 2.4 eq.) was added to a solution of oxalylchloride (2.45 mL, 1.48 g/mL, 28.5 µmol, 1.2 eq.) in 60 mL DCM at −60 °C and stirred for 10 min. 2.21 mL (900 mg/mL, 23.8 µmol, 1.0 eq.) 4-pentyn-1-ol was added in 20 mL DCM and the mixture was stirred for 15 min before 16.5 mL (726 mg/mL, 119 µmol, 5.0 eq.) triethylamine was added and the mixture was allowed to thaw to 0 °C. After 9.54 g (28.5 µmol, 1.2 eq.) Ph3PCHO2Me were added, the reaction was stirred for 90 min at room temperature, 100 mL water was added and the mixture was extracted with DCM (3×25 mL). The organic layer was dried over Na2SO4 and the solvent was removed under reduced pressure. The crude product was purified by column chromatography (hexane/ethyl acetate 15/1 to 10/1) and yielded 2.05 g (62%) of a yellow oil. Rf =0.52 (hexane / ethyl acetate 10/1). (E)-hept-2-en-6-ynoic acid (30) [30] NaOH (22.0 mL, 1 M aq. solution, 21.7 mmol, 1.5 eq.) was added to a solution of 2.00 g (14.5 mmol, 1.0 eq.) compound 29 in 20 mL tetrahydrofuran (THF) and the reaction mixture was stirred at 50 °C for 1 h. Subsequently HCl (25 mL, 1 M aq. solution, 24.6 µmol, 1.7 eq.) was added and the mixture was extracted with ethyl acetate (2×25 mL), the organic layer was dried over Na2SO4 and the solvent was removed under reduced pressure. The crude product was purified by column chromatography (hexane/ethyl acetate 5/1 + 1% acetic acid) and yielded 335 mg (20%) of a yellow oil. Rf =0.63
(hexane/ethyl acetate 5/1 + 1% acetic acid). Washing steps were carried out with 2 mL aqueous solution each. All of the crude product was deprotected according to general procedure B, using trifluoroacetic acid (3.0 mL, 40% in DCM) for 1 h.
All of the deprotected product was used for the amide synthesis according to general procedure C, 
2-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)ethyl(S)-2-((tert-butoxycarbonyl)amino)-3-(3,5difluorophenyl)propanoate (31)
Amino acid derivative 31 was synthesized according to general procedure A, using 50.0 mg (166 µmol, 1.0 eq.) N-Boc-3,5-difluoro-phenylalanine, 22.9 mg (166 µmol, 1.0 eq.) minimal photocrosslinker 32 (2- 
2-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)ethyl(S,E)-3-(3,5-difluorophenyl)-2-(hept-2enamido)propanoate (235)
Synthesis was performed according to general procedure B, using 64.0 mg (152 µmol, 1.0 eq.) amino acid 31 and trifluoroacetic acid (1.5 mL, 40% in DCM) for 1.5 h. All of the crude product was used for the amide synthesis according to general procedure C, using 21.0 µL (960 mg/mL, 154 µmol, 1.0 eq.) [26] N-Boc-trans-4-hydroxy-L-proline methyl ester (5.00 g 20.4 mmol, 1.0 eq.) was dissolved in 18 mL dichloromethane and after the solution was cooled to 0 °C, 6.42 mL (982 mg/mL, 79.5 mmol, 3.9 eq.) pyridine was added slowly. 7.77 g (40.8 mmol, 2.0 eq.) p-TsCl was dissolved in 18 mL dichloromethane and added slowly to the reaction mixture. The mixture was allowed to warm up to room temperature and was stirred for 72 h. After TLC control, water was added, the phases were separated, the organic layer was dried over Na2SO4, and the solvent was removed under reduced pressure. The crude product was purified by column chromatography (hexane/ethyl acetate 2/1) and yielded 6.78 g (83%) of the colourless product. Rf=0.28 (hexane/ethyl acetate 5/1). Analytical data are in accordance with those published in the literature. [26] (2S,4R)-1-(tert-butoxycarbonyl)-4-(tosyloxy)pyrrolidine-2-carboxylic acid (23) [26] LiOH·H2O (3.49 g, 83.2 mmol, 4.9 eq.) was added slowly to a solution of 6.78 g (16.9 mmol, 1.0 eq.) proline derivative 22 in 300 mL tetrahydrofuran/water (3/2). The reaction mixture was stirred for 20 h at room temperature. After reaction control, the mixture was brought to pH 2 with 1 M HCl (aq.) and extracted with ethyl acetate (3×150 mL). The organic layer was dried over Na2SO4 and the solvent was removed under reduced pressure. 6.01 g (15.6 mmol, 93%) of the pure product was obtained as yellow oil. Rf=0.35 (hexane/ethyl acetate 1/1+1%AcOH). Analytical data are in accordance with those published in the literature. [26] (2S,4R)-1-(tert-butoxycarbonyl)-4-methylpyrrolidine-2-carboxylic acid (24) [26] Methyllithium (1.6 M in diethylether, 5.68 mL, 9.08 mmol, 5.0 eq.) was added to a solution of CuCN (627 mg, 7.01 mmol, 2.7 eq.) in 14 mL THF at -78 °C. The reaction mixture was warmed up and stirred for 15 min at 0 °C. Subsequently the reaction mixture was cooled to -78 °C again, and 1.00 g (2.55 mmol, 1.0 eq.) proline derivative 23 in 9.3 mL tetrahydrofuran was added slowly. The reaction mixture was warmed up to -20 °C quickly and was further allowed to warm up to 0 °C in 3 h. After the reaction mixture was cooled to -20 °C again, saturated NH4Cl solution was added until no reaction could be observed anymore. The mixture was allowed to warm up to room temperature overnight. 30 mL 1 M HCl (aq.) was added, followed by 10 mL water. After the mixture was extracted with chloroform (3×55 mL), the organic layer was dried over Na2SO4 and the solvent was removed under reduced pressure. The crude product was purified by column chromatography (hexane/ethyl acetate 2/1) and Trans/cis ratio was determined to be 9/1 by 1 H-NMR of the corresponding HCl salt and comparison to published data. Analytical data are in accordance with those already published in the literature. [26] (2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-methylpyrrolidine-2-carboxylic acid (11) [26, 31] The Boc-protected amino acid derivative 24 (454 mg, 1.98 mmol, 1.0 eq.) was dissolved in 40 mL 4 M HCl in dioxane under argon atmosphere and the reaction mixture was stirred overnight at room temperature. After the solvent was removed under reduced pressure it was diluted in chloroform and the solvent was removed again thrice.
Synthesized amino acid derivatives for ADEP synthesis
1-(tert-butyl) 2-methyl (2S,4R)-4-(tosyloxy)pyrrolidine-1,2-dicarboxylate (22)
The crude product was diluted in 12 mL dioxane and 24 mL of an aqueous 10% Na2CO3 solution was added slowly and the reaction mixture was stirred for 5 min. After the mixture was cooled to -5 °C,
Fmoc-Cl (493 mg, 1.90 mmol, 1.0 eq.) in 18 mL dioxane was added and stirred at room temperature for 3 h. Subsequently the reaction mixture was acidified to pH 2 with concentrated HCl, then 60 mL water was added. After the mixture was extracted with chloroform (3×70 mL), the organic layer was washed with saturated NaCl solution and dried over Na2SO4. Analytical data are in accordance with those published in the literature. [31] (S)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)piperidine-2-carboxylic acid (13) [32] Fmoc-Cl (2.20 g, 8.52 mmol, 1.1 eq.) in 33 mL dioxane was added to a solution of 1.00 g (7.74 mmol, 1.0 eq.) pipecolic acid and 4.10 g (37.7 mmol, 5.0 eq.) Na2CO3 in 33 mL water and the reaction mixture was stirred for 72 h at room temperature. Subsequently 50 mL water was added and the mixture was washed with diethylether (3×10 mL). The aqueous phase was acidified (pH 2, conc. HCl), extracted with ethyl acetate (3×15 mL) and the organic layer was washed with saturated NaCl solution (1×15 mL) and dried over Na2SO4. The solvent was removed under reduced pressure and the crude product was purified by column chromatography (hexane/ethyl acetate 1/1 + 1% acetic acid) to yield 2.01 g (74%) of the colourless product. Analytical data are in accordance with those published in the literature. [32] (S)-1-(tert-butoxycarbonyl)-4-oxopyrrolidine-2-carboxylic acid (25)
2.00 g (8.65 mmol, 1.0 eq.) Trichloroisocyanuric adic (TCCA) was added to 2.00 g (8.65 mmol, 1.0 eq.)
Boc-L-hydroxyproline in 40 mL DCM, the solution was cooled to 0 °C and 67.0 mg (432 µmol, 0.1 eq.) 2,2,6,6-Tetramethylpiperidinyloxyl (TEMPO) was added and the reaction mixture was stirred for 30 min at 0 °C and 3 h at room temperature. Subsequently 20 mL water was added and the solvents removed under reduced pressure. The resulting slurry was taken up in 30 mL ethyl acetate, filtered through Celite ® and the solution was acidified with 1 M HCl (aq.) to pH 4. The organic layer was washed with water (3×10 mL) and saturated NaCl solution (10 mL), dried over Na2SO4 and the solvent was removed under reduced pressure. 1.70 g (86%) of a light brown solid was obtained as pure product. Analytical data are in accordance with those published in the literature. [33, 34] (S)-5-(tert-butoxycarbonyl)-1,2,5-triazaspiro[2.4]hept-1-ene-6-carboxylic acid (26) 9.35 mL (7 N in MeOH, 65.4 mmol, 15 eq.) NH3 was added to a solution of 1.00 g (4.36 mmol, 1.0 eq.) ketone 25 in 3.5 mL MeOH under argon atmosphere at -10 °C. After the reaction mixture was stirred at -10 °C for 5 h, 641 mg (5.67 mmol, 1.3 eq.) hydroxylamine-O-sulfonic acid in 4 mL MeOH was added at -78 °C and the reaction mixture was stirred for 1.5 h at -10 °C. The mixture was allowed to warm up to room temperature, stirred for 16 h and filtered off and washed with methanol (10 mL). Subsequently 1.22 mL (726 mg/mL, 8.77 mmol, 2.0 eq.) NEt3 was added and the reaction was cooled to 0 °C before 1.44 g (5.67 mmol, 1.3 eq.) iodine (in 25 mL MeOH) was added, until a brown colour did not disappear.
The reaction mixture was stirred for 2 h at 0 °C before the solvent was removed under reduced pressure.
The resulting slurry was taken up in 25 mL water, brought to pH 2 with 1 M HCl (aq.) and extracted with ethyl acetate (4×8 mL). The organic layer was washed with saturated NaCl solution (3×10 mL) and dried over Na2SO4. The solvent was removed under reduced pressure and the crude product was purified by reversed phase HPLC (ACN/H2O; ACN 2% to 98%) and yielded 166 mg (11%) of the pure product. Analytical data are in accordance with those published in the literature. [33, 34] (S)-5-(((9H-fluoren-9-yl)methoxy)carbonyl)-1,2,5-triazaspiro[2.4]hept-1-ene-6-carboxylic acid (12) 0.66 mL conc. HCl was added to a solution of 280 mg (1.16 mmol, 1.0 eq.) diazirine 26 in 6 mL dioxane, the reaction mixture was stirred for 2 h and the solvent was removed under reduced pressure. The resulting slurry was taken up in 10 mL water and lyophilized overnight. The brown oil was diluted in 5.6 mL of a 9% Na2CO3 aqueous solution and 353 mg (1.05 mmol, 0.9 eq.) Fmoc-succinimide in 1.2 mL DMF/dioxane (1/1) was added and the reaction stirred for 5 min. Subsequently 6.3 mL DMF/dioxane (1/1) were added and the mixture was stirred for 10 min before 25 mL water was added. After the mixture was washed with diethylether (20 mL) and ethyl acetate (20 mL), the aqueous layer was acidified with conc. HCl to pH 2. The aqueous phase was extracted with ethyl acetate (5×20 mL), dried over Na2SO4 and the solvent was removed under reduced pressure. The crude product was purified by reversed phase HPLC (ACN/H2O; ACN 2% to 98%) and 331 mg (73%) pure product was obtained. Analytical data are in accordance with those published in the literature. [33, 34] 
General procedures for solid phase peptide synthesis and cyclisation
General Procedure D: Loading of the resin.
The weight of a syringe fitted with a frit was determined, the resin (2-chlorotrityl chloride resin, 100-200 mesh, loading: 0.958 mmol/g) was added, and the weight determined again. The amino acid was dissolved in 3 mL dichloromethane, 140 µL DIPEA were added, the solution was filled into the syringe and was shaken for 4 h. Subsequently 0.5 mL methanol was added and the syringe was shaken for 15 min. Then the resin was washed with DCM (1×5 mL), DMF (3×5 mL), DCM (3×5 mL) and MeOH (2×5 mL), before it was dried for 3 h in a desiccator. The weight of the syringe with resin was determined again and the load of the resin was calculated with the following equation (1, m1=weight of unloaded resin, m2=weight of loaded resin).
= ( 2 − 1 ) * 1000 ( − ) * 2 (1)
General Procedure E: Deprotection of amino acids.
Before the first deprotection, the resin was shaken with 5 mL DMF for 20 min. For the deprotection, the resin was shaken with 5 mL 20% piperidine in DMF for 10 min, the same procedure was repeated for another 5 min. After that, the resin was washed with 5 mL DMF (3×2 min).
General Procedure F: Coupling of amino acids
HATU (154 mg, 410 µmol) in DMF (2.0 mL) was added to the corresponding amino acid in DMF (2.0 mL) followed by DIPEA (198 µL, 742 mg/mL, 1.14 mmol) in DMF (0.5 mL) and nitrogen was forced through the solution for 5 min. 2.5 mL DMF was added to the resin, followed by the amino acid mixture. The resin was shaken for 2 h and then washed with DMF (5×5 mL). A chloranil test was performed after each coupling to check for completion of the reaction.
General Procedure G: Execution of the chloranil test.
A few resin beads were washed with DCM and given in a small reaction vessel. 200 µL aceton or acetaldehyde was added for secondary or primary amines, respectively. After 50 µL chloranil (saturated solution in toluol) was added, the mixture was shaken for 10 min. When the resin beads turned blue or green, the coupling step was repeated.
General Procedure H: Cleavage of the resin.
The resin was shaken with 7 mL DMF (2×5 min) and 7 mL methanol (3×5 min) and dried under high vacuum. Then, 1.5 mL triisopropylsilane and 0.3 mL TFA in 4 mL DCM was added and rinsed with 2 mL DCM. After the mixture was shaken for 1 h, the solution was given into a flask and the procedure was Analytical data are in accordance with those published in the literature. [31] 
